Unlocking potential in Life Sciences: collaborative research between Academia and Industry in Europe

The process of technology transfer in the Life Sciences domain aims to advance early scientific inventions and discoveries to the next generation of diagnostics, therapies, services, and enterprises. Thanks to its intrinsic attitude to risk, hypothesis-driven research, and data sharing, academia produces a large amount of highly valuable discoveries and inventions that, regrettably, very often do not translate into therapies and products beneficial for society. This is because the journey from academic research to patients requires competencies, know-how, and access to large scientific, human, and economic resources. Very often, academia spinoffs and start-ups do not have enough resources and know-how to tackle all these challenges. On the other hand, the industry has been thriving in delivering breakthrough therapies and diagnostic tools to patients. Still, it is less effective than academia in producing breakthrough scientific discoveries. Collaboration between academia and industry is essential to unleashing the full potential of both worlds and in Europe, there are several models of such collaborations. With this in mind, we would like to bring together some of the key players in the Italian Life Science ecosystem to analyse such European examples and join efforts to build a model for Italy.

From 09:15 to 13:00 CEST